Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

The guy that was very angry with Kush Dhody is a w

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153886
(Total Views: 824)
Posted On: 07/13/2020 4:57:43 PM
Posted By: biloxiblues
The guy that was very angry with Kush Dhody is a writer for seeking alpha,what a buffoon.

Check out

Kush Dhody utilizes his 15 years of experience in clinical research and pharmaceutical product development to provide strategic direction for the implementation and execution of clinical trials and to oversee the operational delivery of clinical study programs.

As a clinician, he has managed Phase I-IV studies in a CRO environment and for mid-to-large pharmaceutical and biotechnology companies. He has also served as a study site investigator.

Dr. Dhody has held several leadership positions in clinical operations and drug development, while executing clinical development programs from IND through NDA. Serving as Clinical Program Director for several NCE development projects, he has a highly successful track record of managing diverse cross-functional teams from data management, biometrics, regulatory affairs, clinical compliance and pharmacovigilance, and of serving as liaison for investigators and clinical site staff to achieve overall project delivery.

Additionally, Dr. Dhody has written/developed 20-plus protocols and prepared several individual and integrated study reports and co-lead teams in preparation of ISEs and ISSs.

His areas of expertise include:

Good Clinical Practice (GCP)
Clinical project management
Clinical monitoring
Training
Trial design and execution strategy
Clinical development consulting
Oncology


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us